Used in pharmaceutical research as a key intermediate in the synthesis of central nervous system agents, particularly for developing serotonin and dopamine modulators. Shows potential in the design of treatments for neurological disorders such as depression, anxiety, and Parkinson’s disease due to its structural affinity for monoamine transporters. Also employed in the development of fluorinated analogs to enhance blood-brain barrier penetration and metabolic stability in drug candidates.